Ionis Pharmaceuticals Inc (IONS) — Cash Flow Reinvestment Rate
Ionis Pharmaceuticals Inc (IONS) has a Cash Flow Reinvestment Rate of 0.10x as of June 2026, reinvesting $57.81 Million (capex $16.08 Million plus investments $41.73 Million) from operating cash flow of $565.53 Million. See Ionis Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ionis Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for Ionis Pharmaceuticals Inc across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ionis Pharmaceuticals Inc.
Annual Cash Flow Reinvestment Rate for Ionis Pharmaceuticals Inc (2007–2021)
Year-by-year capital reinvestment analysis for Ionis Pharmaceuticals Inc. See IONS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 7.49x | $230.71 Million | $30.80 Million | $17.90 Million | ▼ -24.6% |
| 2020 | 9.93x | $356.57 Million | $35.89 Million | $41.05 Million | ▲ +8221.4% |
| 2019 | 0.12x | $41.27 Million | $345.72 Million | $36.28 Million | ▼ -92.3% |
| 2018 | 1.54x | $929.56 Million | $602.89 Million | $17.65 Million | ▼ -25.1% |
| 2017 | 2.06x | $358.29 Million | $174.15 Million | $37.86 Million | ▼ -27.7% |
| 2015 | 2.85x | $60.10 Million | $21.12 Million | $11.75 Million | ▼ -79.0% |
| 2014 | 13.57x | $85.31 Million | $6.29 Million | $11.10 Million | ▲ +233.8% |
| 2013 | 4.07x | $258.15 Million | $63.49 Million | $5.36 Million | ▼ -74.5% |
| 2012 | 15.97x | $29.95 Million | $1.88 Million | $5.17 Million | ▲ +19735.1% |
| 2008 | 0.08x | $17.07 Million | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $5.01 Million | $36.09 Million | $5.01 Million | — |